Meet the Founder
Marcel V. Alavi, Ph.D.
Marcel's deep expertise in organelle biology began more than twenty years ago while a student at the Ludwig-Maximilians-University in Munich, Germany, where he earned a Master's in Cell Biology & Biochemistry in 2004. He went on to earn his Ph.D. summa cum laude at the Eberhard-Karls University in Tübingen in 2010, focusing his research on the molecular basis of ADOA, a genetic form of childhood blindness linked to mitochondrial defects.
He held postdoctoral scientist positions at the Johannes-Gutenberg University in Mainz, Germany, and the University of California, San Francisco, where he studied intraflagellar transport proteins and vascular basement membrane defects, respectively.
In 2016, Marcel founded 712 North with the goal of targeting mitochondrial inner membrane proteases to develop therapies for patients with fatal aging-related diseases. He is an inventor on 4 patents and has authored 27 peer-reviewed research articles.
712 North at the BIO Investor Forum 2019 in San Francisco, CA
Contact us
Interested in learning more or working together? Fill out some info and we will be in touch shortly. We can’t wait to hear from you!